Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PBYIPUMA BIOTECHNOLOGY, INC.

Nasdaq · CIK 0001401667
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts408

Identity from submissions API

NamePUMA BIOTECHNOLOGY, INC.
CIK0001401667
TickersPBYI
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN770683487
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(424) 248-6500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • INNOVATIVE ACQUISITIONS CORP (2007-09-14T04:00:00.000Z → 2011-10-04T04:00:00.000Z)
Business address
10880 WILSHIRE BLVD.
SUITE 1700
LOS ANGELES
CA
CA
Mailing address
10880 WILSHIRE BLVD.
SUITE 1700
LOS ANGELES
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1127 filing rows loaded from submissions recent; extra archives: CIK0001401667-submissions-001.json (126 filings, 2007-09-14 to 2012-11-12).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000052388-26-000503 005-83367 261558759 34 14529
2026-11-13 4 FORM 4 0001437749-26-036984 5311
2026-11-12 144 xsl144X01/primary_doc.xml 0001959173-26-007942 001-35703 261543227 33 4748
2026-11-09 10-Q FORM 10-Q 0001437749-26-035912 001-35703 261536520 34 9256972 1 1
2026-11-05 8-K FORM 8-K 2.02,9.01 0001437749-26-035279 001-35703 261527492 34 473190 1 1
2026-10-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-114167 005-83367 261445326 34 10740
2026-09-16 4 FORM 4 0001437749-26-030597 6006
2026-09-16 4 FORM 4 0001437749-26-030593 8591
2026-09-14 144 xsl144X01/primary_doc.xml 0001959173-26-006918 001-35703 261376472 33 5049
2026-09-14 144 xsl144X01/primary_doc.xml 0001959173-26-006917 001-35703 261376461 33 4551
2026-08-06 10-Q FORM 10-Q 0001437749-26-026311 001-35703 261249925 34 9085516 1 1
2026-08-06 8-K FORM 8-K 2.02,9.01 0001437749-26-026282 001-35703 261249426 34 435313 1 1
2026-07-08 4 FORM 4 0001437749-26-023079 4759
2026-07-08 4 FORM 4 0001437749-26-023078 4801
2026-07-08 4 FORM 4 0001437749-26-023077 4709
2026-07-06 144 xsl144X01/primary_doc.xml 0001959173-26-005126 001-35703 261156689 33 4612
2026-07-06 144 xsl144X01/primary_doc.xml 0001959173-26-005123 001-35703 261156618 33 4581
2026-07-06 144 xsl144X01/primary_doc.xml 0001959173-26-005121 001-35703 261156550 33 4592
2026-06-16 8-K FORM 8-K 5.07 0001437749-26-020793 001-35703 261094636 34 193251 1 1
2026-06-15 4 FORM 4 0001437749-26-020709 8233
2026-06-15 4 FORM 4 0001437749-26-020708 6823
2026-06-15 4 FORM 4 0001437749-26-020706 6862
2026-06-15 4 FORM 4 0001437749-26-020705 5124
2026-06-15 4 FORM 4 0001437749-26-020704 6854
2026-06-15 4 FORM 4 0001437749-26-020703 6859
2026-06-15 4 FORM 4 0001437749-26-020702 4800
2026-06-12 144 xsl144X01/primary_doc.xml 0001959173-26-004590 001-35703 261085327 33 4560
2026-06-12 144 xsl144X01/primary_doc.xml 0001959173-26-004589 001-35703 261085323 33 4550
2026-06-12 144 xsl144X01/primary_doc.xml 0001959173-26-004588 001-35703 261085318 33 4553
2026-06-12 144 xsl144X01/primary_doc.xml 0001959173-26-004586 001-35703 261085293 33 4512
2026-06-12 144 xsl144X01/primary_doc.xml 0001959173-26-004584 001-35703 261085206 33 4553
2026-05-07 10-Q FORM 10-Q 0001437749-26-015633 001-35703 26954309 34 7440821 1 1
2026-05-07 8-K FORM 8-K 2.02,9.01 0001437749-26-015621 001-35703 26954148 34 337624 1 1
2026-04-28 DEFA14A FORM DEFA14A 0001437749-26-013674 001-35703 26908086 34 1101671
2026-04-28 ARS FORM ARS 0001437749-26-013673 001-35703 26908066 34 18269268
2026-04-28 DEF 14A FORM DEF 14A 0001437749-26-013671 001-35703 26908019 34 2958667 1 1
2026-04-07 PRE 14A FORM PRE 14A 0001437749-26-011631 001-35703 26845692 34 2952735 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002190 005-83367 26803235 34 7295
2026-02-26 10-K FORM 10-K 0001437749-26-005891 001-35703 26689671 34 11203072 1 1
2026-02-26 8-K FORM 8-K 2.02,9.01 0001437749-26-005869 001-35703 26688388 34 410464 1 1
2026-02-20 4 FORM 4 0001437749-26-004948 7410
2026-02-20 4 FORM 4 0001437749-26-004947 7353
2026-02-20 4 FORM 4 0001437749-26-004946 7262
2026-01-08 4 FORM 4 0001437749-26-000924 6039
2026-01-08 4 FORM 4 0001437749-26-000922 6092
2026-01-08 4 FORM 4 0001437749-26-000921 6000
2026-01-07 144 xsl144X01/primary_doc.xml 0001959173-26-000194 001-35703 26516015 33 5286
2026-01-07 144 xsl144X01/primary_doc.xml 0001959173-26-000193 001-35703 26515978 33 5266
2026-01-07 144 xsl144X01/primary_doc.xml 0001959173-26-000192 001-35703 26515969 33 5275
2026-01-06 144 xsl144X01/primary_doc.xml 0001959173-26-000171 001-35703 26512483 33 4634
2026-01-06 144 xsl144X01/primary_doc.xml 0001959173-26-000167 001-35703 26512399 33 4629
2026-01-06 144 xsl144X01/primary_doc.xml 0001959173-26-000165 001-35703 26512374 33 4642
2025-11-13 4 FORM 4 0001437749-25-034874 5203
2025-11-12 144 xsl144X01/primary_doc.xml 0001959173-25-006907 001-35703 251469280 33 4782
2025-11-06 10-Q FORM 10-Q 0001437749-25-033633 001-35703 251459141 34 8238434 1 1
2025-11-06 8-K FORM 8-K 2.02,9.01 0001437749-25-033604 001-35703 251458516 34 406778 1 1
2025-08-07 10-Q FORM 10-Q 0001437749-25-025470 001-35703 251194879 34 8253604 1 1
2025-08-07 8-K FORM 8-K 2.02,9.01 0001437749-25-025463 001-35703 251194718 34 412156 1 1
2025-08-07 10-Q/A FORM 10-Q/A 0001437749-25-025214 001-35703 251191306 34 242544 1 1
2025-07-22 4 FORM 4 0001437749-25-023268 5011
2025-07-18 144 xsl144X01/primary_doc.xml 0001959173-25-004647 001-35703 251134689 33 5193
2025-07-10 4 FORM 4 0001437749-25-022551 6001
2025-07-10 4 FORM 4 0001437749-25-022549 6093
2025-07-10 4 FORM 4 0001437749-25-022547 6040
2025-07-09 144 xsl144X01/primary_doc.xml 0001959173-25-004521 001-35703 251114064 33 5276
2025-07-09 144 xsl144X01/primary_doc.xml 0001959173-25-004519 001-35703 251113964 33 5289
2025-07-09 144 xsl144X01/primary_doc.xml 0001959173-25-004517 001-35703 251113873 33 5267
2025-07-08 144 xsl144X01/primary_doc.xml 0001959173-25-004506 001-35703 251111453 33 4650
2025-07-08 144 xsl144X01/primary_doc.xml 0001959173-25-004505 001-35703 251111435 33 4630
2025-07-08 144 xsl144X01/primary_doc.xml 0001959173-25-004503 001-35703 251111341 33 4630
2025-06-24 8-K FORM 8-K 5.03,9.01 0001437749-25-021153 001-35703 251069010 34 346419 1 1
2025-06-17 4 FORM 4 0001437749-25-020721 6424
2025-06-17 4 FORM 4 0001437749-25-020719 5010
2025-06-17 4 FORM 4 0001437749-25-020717 5066
2025-06-17 4 FORM 4 0001437749-25-020715 4886
2025-06-17 4 FORM 4 0001437749-25-020713 5047
2025-06-17 4 FORM 4 0001437749-25-020711 5010
2025-06-13 4 FORM 4 0001437749-25-020363 4941
2025-06-13 4 FORM 4 0001437749-25-020362 4749
2025-06-13 4 FORM 4 0001437749-25-020361 4569
2025-06-13 4 FORM 4 0001437749-25-020360 4730
2025-06-13 4 FORM 4 0001437749-25-020359 4695
2025-06-13 4 FORM 4 0001437749-25-020358 6107
2025-06-13 4 FORM 4 0001437749-25-020357 4693
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004074 001-35703 251046753 33 4585
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004071 001-35703 251046651 33 4602
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004070 001-35703 251046645 33 4583
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004069 001-35703 251046613 33 4552
2025-06-13 8-K FORM 8-K 5.07 0001437749-25-020321 001-35703 251046568 34 176956 1 1
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004068 001-35703 251046566 33 4542
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004067 001-35703 251046416 33 4419
2025-05-21 144 xsl144X01/primary_doc.xml 0001959173-25-003393 001-35703 25972841 33 4490
2025-05-09 8-K FORM 8-K 5.02 0001437749-25-015648 001-35703 25928563 34 161167 1 1
2025-05-08 10-Q FORM 10-Q 0001437749-25-015533 001-35703 25926984 34 7466137 1 1
2025-05-08 8-K FORM 8-K 2.02,9.01 0001437749-25-015514 001-35703 25926534 34 335505 1 1
2025-04-28 DEFA14A FORM DEFA14A 0001437749-25-013339 001-35703 25880673 34 420271
2025-04-28 ARS ARS 0001437749-25-013338 001-35703 25880653 34 12351831
2025-04-28 DEF 14A FORM DEF 14A 0001437749-25-013337 001-35703 25880634 34 2958658 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000642 005-83367 25844572 34 10878
2025-02-27 10-K FORM 10-K 0001437749-25-005496 001-35703 25679932 34 10620239 1 1
2025-02-27 8-K FORM 8-K 2.02,9.01 0001437749-25-005477 001-35703 25679246 34 391968 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-25-000007 005-83367 25625560 34 12219
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-003981 005-83367 25624969 34 37675
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001654954-25-001504 005-83367 25623484 34 12001
2025-02-11 4 FORM 4 0001437749-25-003461 7209
2025-02-11 4 FORM 4 0001437749-25-003459 7224
2025-02-11 4 FORM 4 0001437749-25-003456 7301
2025-02-11 4 FORM 4 0001437749-25-003454 7297
2025-02-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-008607 005-83367 25582406 34 18447
2025-01-03 4 FORM 4 0001437749-25-000365 5149
2025-01-03 4 FORM 4 0001437749-25-000363 5163
2025-01-03 4 FORM 4 0001437749-25-000361 5240
2025-01-03 4 FORM 4 0001437749-25-000359 5185
2025-01-02 144 xsl144X01/primary_doc.xml 0001610717-25-000004 001-35703 25503575 33 5179
2025-01-02 144 xsl144X01/primary_doc.xml 0001610717-25-000003 001-35703 25503574 33 5188
2025-01-02 144 xsl144X01/primary_doc.xml 0001610717-25-000002 001-35703 25503572 33 5171
2025-01-02 144 xsl144X01/primary_doc.xml 0001610717-25-000001 001-35703 25503567 33 5850
2024-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-24-000040 005-83367 241459223 34 12364
2024-11-08 SC 13G us74587v1070_110824.txt 0002012383-24-004166 005-83367 241442177 34 13824
2024-11-07 10-Q FORM 10-Q 0001437749-24-033955 001-35703 241436619 34 7879683 1 1
2024-11-07 8-K FORM 8-K 2.02,9.01 0001437749-24-033929 001-35703 241435918 34 393503 1 1
2024-10-22 SC 13G us74587v1070_102224.txt 0002012383-24-001266 005-83367 241386101 34 13812
2024-09-16 8-K FORM 8-K 8.01 0001437749-24-029206 001-35703 241299481 34 173010 1 1
2024-08-27 S-8 FORM S-8 0001437749-24-027862 333-281803 241249906 33 104161
2024-08-15 8-K FORM 8-K 8.01 0001437749-24-026953 001-35703 241210798 34 170463 1 1
2024-08-13 4 FORM 4 0001437749-24-026536 5357
2024-08-12 144 xsl144X01/primary_doc.xml 0001610717-24-000426 001-35703 241198523 33 5304
2024-08-07 8-K FORM 8-K 8.01 0001437749-24-025027 001-35703 241181755 34 165171 1 1
2024-08-01 10-Q FORM 10-Q 0001437749-24-024309 001-35703 241167416 34 7809445 1 1
2024-08-01 8-K FORM 8-K 2.02,9.01 0001437749-24-024297 001-35703 241166972 34 386442 1 1
2024-07-18 4 FORM 4 0001437749-24-023022 5152
2024-07-18 4 FORM 4 0001437749-24-023020 5167
2024-07-18 4 FORM 4 0001437749-24-023017 5244
2024-07-18 4 FORM 4 0001437749-24-023014 5189
2024-07-17 144 xsl144X01/primary_doc.xml 0001610717-24-000402 001-35703 241123520 33 5269
2024-07-17 144 xsl144X01/primary_doc.xml 0001610717-24-000401 001-35703 241123516 33 5283
2024-07-17 144 xsl144X01/primary_doc.xml 0001610717-24-000400 001-35703 241123514 33 5260
2024-07-17 144 xsl144X01/primary_doc.xml 0001610717-24-000399 001-35703 241123512 33 5352
2024-07-02 4 FORM 4 0001437749-24-022067 5151
2024-07-02 4 FORM 4 0001437749-24-022065 5166
2024-07-02 4 FORM 4 0001437749-24-022063 5243
2024-07-02 4 FORM 4 0001437749-24-022061 5188
2024-07-02 144 xsl144X01/primary_doc.xml 0001610717-24-000388 001-35703 241098014 33 4591
2024-07-02 144 xsl144X01/primary_doc.xml 0001610717-24-000387 001-35703 241098011 33 4601
2024-07-02 144 xsl144X01/primary_doc.xml 0001610717-24-000386 001-35703 241097997 33 4584
2024-07-02 144 xsl144X01/primary_doc.xml 0001610717-24-000385 001-35703 241097992 33 5260
2024-06-24 8-K FORM 8-K 5.02,5.07,9.01 0001437749-24-021086 001-35703 241064499 34 207110 1 1
2024-06-21 4 FORM 4 0001437749-24-021024 6114
2024-06-21 4 FORM 4 0001437749-24-021022 4701
2024-06-21 4 FORM 4 0001437749-24-021020 4756
2024-06-21 4 FORM 4 0001437749-24-021018 4948
2024-06-21 4 FORM 4 0001437749-24-021016 4576
2024-06-21 4 FORM 4 0001437749-24-021014 4737
2024-06-21 4 FORM 4 0001437749-24-021012 4700
2024-06-17 4 FORM 4 0001437749-24-020574 6457
2024-06-17 4 FORM 4 0001437749-24-020572 5045
2024-06-17 4 FORM 4 0001437749-24-020570 5097
2024-06-17 4 FORM 4 0001437749-24-020568 4921
2024-06-17 4 FORM 4 0001437749-24-020566 5082
2024-06-13 144 xsl144X01/primary_doc.xml 0002001666-24-000010 001-35703 241042911 33 4587
2024-06-13 144 xsl144X01/primary_doc.xml 0002001666-24-000009 001-35703 241042906 33 4545
2024-06-13 144 xsl144X01/primary_doc.xml 0002001666-24-000008 001-35703 241042904 33 4601
2024-06-13 144 xsl144X01/primary_doc.xml 0002001666-24-000007 001-35703 241042902 33 4421
2024-06-13 144 xsl144X01/primary_doc.xml 0002001666-24-000006 001-35703 241042900 33 4582
2024-05-17 8-K FORM 8-K 8.01 0001437749-24-017504 001-35703 24960589 34 162736 1 1
2024-05-02 10-Q FORM 10-Q 0001437749-24-014395 001-35703 24909193 34 7143267 1 1
2024-05-02 8-K FORM 8-K 2.02,9.01 0001437749-24-014382 001-35703 24908578 34 326953 1 1
2024-04-26 DEFA14A FORM DEFA14A 0001437749-24-013311 001-35703 24878919 34 396963
2024-04-26 ARS pbyiars.pdf 0001437749-24-013310 001-35703 24878913 34 7964088
2024-04-26 DEF 14A FORM DEF 14A 0001437749-24-013309 001-35703 24878909 34 3725835 1 1
2024-03-29 SC 13G SC 13G 0001193125-24-081657 005-83367 24802501 34 322559
2024-03-19 4 FORM 4 0001437749-24-008575 7556
2024-03-19 8-K FORM 8-K 8.01 0001437749-24-008508 001-35703 24763033 34 164700 1 1
2024-02-29 10-K FORM 10-K 0001437749-24-006121 001-35703 24704525 34 10323059 1 1
2024-02-29 8-K FORM 8-K 2.02,9.01 0001437749-24-006099 001-35703 24703867 34 391065 1 1
2024-02-14 4 FORM 4 0001437749-24-004218 7198
2024-02-14 4 FORM 4 0001437749-24-004216 7209
2024-02-14 4 FORM 4 0001437749-24-004214 7224
2024-02-14 4 FORM 4 0001437749-24-004211 7292
2024-02-14 4 FORM 4 0001437749-24-004207 7301
2024-02-14 SC 13G/A PRIMARY DOCUMENT 0001654954-24-001699 005-83367 24632523 34 67472
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021773 005-83367 24629312 34 13185
2024-02-06 SC 13G/A PUMA BIOTECHNOLOGY, INC. 0000902664-24-001097 005-83367 24600039 34 104987
2024-01-30 SC 13G/A PBYI_SC13GA2_2024.htm 0001273087-24-000028 005-83367 24578215 34 96011
2024-01-18 8-K FORM 8-K 7.01,9.01 0001437749-24-001581 001-35703 24540219 34 11282761 1 1
2024-01-10 4 FORM 4 0001437749-24-001115 5140
2024-01-10 144/A xsl144X01/primary_doc.xml 0001842612-24-000003 001-35703 24527020 33 5989
2024-01-05 4 FORM 4 0001437749-24-000776 5143
2024-01-05 4 FORM 4 0001437749-24-000773 5170
2024-01-05 4 FORM 4 0001437749-24-000770 12044
2024-01-05 4 FORM 4 0001437749-24-000768 5156
2024-01-05 4 FORM 4 0001437749-24-000765 5247
2024-01-03 144 xsl144X01/primary_doc.xml 0002006196-24-000006 001-35703 24509630 33 5767
2024-01-03 144 xsl144X01/primary_doc.xml 0002006196-24-000005 001-35703 24509627 33 5777
2024-01-03 144 xsl144X01/primary_doc.xml 0002006196-24-000004 001-35703 24509625 33 5166
2024-01-03 144 xsl144X01/primary_doc.xml 0002006196-24-000003 001-35703 24509621 33 5759
2024-01-03 144 xsl144X01/primary_doc.xml 0002006196-24-000002 001-35703 24509612 33 5782
2023-11-09 4 FORM 4 0001437749-23-031275 5056
2023-11-07 144 xsl144X01/primary_doc.xml 0001967196-23-000001 001-35703 231385671 33 5222
2023-11-02 10-Q FORM 10-Q 0001437749-23-030028 001-35703 231373109 34 7782471 1 1
2023-11-02 8-K FORM 8-K 2.02,9.01 0001437749-23-030014 001-35703 231372614 34 382572 1 1
2023-09-26 8-K FORM 8-K 7.01 0001437749-23-026766 001-35703 231280570 34 155220 1 1
2023-09-01 SC 13G PUMA BIOTECHNOLOGY, INC. 0000902664-23-004670 005-83367 231230993 34 109172
2023-08-18 8-K FORM 8-K 5.03,9.01 0001437749-23-024168 001-35703 231186075 34 360241 1 1
2023-08-03 10-Q FORM 10-Q 0001437749-23-021972 001-35703 231140825 34 7783738 1 1
2023-08-03 8-K FORM 8-K 2.02,9.01 0001437749-23-021937 001-35703 231140099 34 356497 1 1
2023-07-06 4 FORM 4 0001437749-23-019528 5059
2023-07-06 4 FORM 4 0001437749-23-019525 5071
2023-07-06 4 FORM 4 0001437749-23-019523 5086
2023-07-06 4 FORM 4 0001437749-23-019521 5162
2023-07-06 4 FORM 4 0001437749-23-019519 12049
2023-07-03 144 xsl144X01/primary_doc.xml 0001230439-23-000011 001-35703 231066362 33 5106
2023-07-03 144 xsl144X01/primary_doc.xml 0001230439-23-000010 001-35703 231066359 33 369536
2023-07-03 144 xsl144X01/primary_doc.xml 0001230439-23-000009 001-35703 231066349 33 312765
2023-07-03 144 xsl144X01/primary_doc.xml 0001230439-23-000008 001-35703 231066345 33 549912
2023-07-03 144 xsl144X01/primary_doc.xml 0001230439-23-000007 001-35703 231066336 33 1436897
2023-06-15 4 FORM 4 0001437749-23-017612 14726
2023-06-15 4 FORM 4 0001437749-23-017610 13331
2023-06-15 4 FORM 4 0001437749-23-017608 13815
2023-06-15 4 FORM 4 0001437749-23-017606 13914
2023-06-15 4 FORM 4 0001437749-23-017604 18190
2023-06-15 4 FORM 4 0001437749-23-017594 6904
2023-06-15 4 FORM 4 0001437749-23-017590 4618
2023-06-15 8-K FORM 8-K 5.07 0001437749-23-017581 001-35703 231018362 34 175504 1 1
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000012 001-35703 231012828 33 648836
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000011 001-35703 231012823 33 419596
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000010 001-35703 231012820 33 3543740
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000009 001-35703 231012805 33 310212
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000008 001-35703 231012804 33 318756
2023-06-13 144 xsl144X01/primary_doc.xml 0001842612-23-000007 001-35703 231012803 33 307575
2023-06-06 4 FORM 4 0001437749-23-016759 5058
2023-06-02 144 xsl144X01/primary_doc.xml 0001842612-23-000003 001-35703 23990702 33 870372
2023-05-04 10-Q FORM 10-Q 0001437749-23-012589 001-35703 23889525 34 7019579 1 1
2023-05-04 8-K FORM 8-K 2.02,9.01 0001437749-23-012576 001-35703 23888991 34 309503 1 1
2023-04-28 DEFA14A FORM DEFA14A 0001437749-23-011502 001-35703 23860424 34 582456
2023-04-28 ARS formars.pdf 0001437749-23-011501 001-35703 23860396 34 19141837
2023-04-28 DEF 14A FORM DEF 14A 0001437749-23-011500 001-35703 23860354 34 3060231 1 1
2023-03-02 10-K FORM 10-K 0001437749-23-005233 001-35703 23699732 34 10639965 1 1
2023-03-02 8-K FORM 8-K 2.02,9.01 0001437749-23-005220 001-35703 23699029 34 362869 1 1
2023-02-14 4 FORM 4 0001437749-23-003388 7084
2023-02-14 4 FORM 4 0001437749-23-003382 7095
2023-02-14 4 FORM 4 0001437749-23-003379 7110
2023-02-14 4 FORM 4 0001437749-23-003375 7187
2023-02-14 4 FORM 4 0001437749-23-003371 7140
2023-02-14 SC 13G/A PRIMARY DOCUMENT 0001654954-23-001644 005-83367 23622861 34 67284
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016787 005-83367 23604062 34 13103
2023-02-07 SC 13G/A PUMA_BIO.txt 0000769993-23-000080 005-83367 23595541 34 23717
2023-01-19 SC 13G/A PBYI_SC13GA1_2023.htm 0001273087-23-000041 005-83367 23537643 34 81606
2023-01-09 8-K FORM 8-K 7.01,9.01 0001437749-23-000699 001-35703 23516858 34 15475830 1 1
2023-01-05 4 FORM 4 0001437749-23-000552 5146
2023-01-05 4 FORM 4 0001437749-23-000547 5159
2023-01-05 4 FORM 4 0001437749-23-000534 5172
2023-01-05 4 FORM 4 0001437749-23-000521 5249
2023-01-05 4 FORM 4 0001437749-23-000512 5157
2022-12-16 8-K FORM 8-K 8.01 0001437749-22-029261 001-35703 221468147 34 155434 1 1
2022-12-13 SC 13D/A SCHEDULE 13D/A 0001437749-22-028938 005-83367 221458190 34 47455
2022-12-13 8-K FORM 8-K 1.01,3.02,9.01 0001437749-22-028937 001-35703 221458186 34 359224 1 1
2022-12-12 4 FORM 4 0001437749-22-028940 4668
2022-12-09 8-K FORM 8-K 7.01,9.01 0001437749-22-028774 001-35703 221453700 34 367911 1 1
2022-12-08 8-K FORM 8-K 7.01,9.01 0001437749-22-028687 001-35703 221451220 34 637564 1 1
2022-12-06 4 FORM 4 0001437749-22-028564 5158
2022-12-06 4 FORM 4 0001437749-22-028559 5250
2022-12-06 4 FORM 4 0001437749-22-028558 5159
2022-12-06 4 FORM 4 0001437749-22-028557 5147
2022-11-10 8-K FORM 8-K 8.01,9.01 0001437749-22-026924 001-35703 221377753 34 214409 1 1
2022-11-04 4 FORM 4 0001437749-22-026041 4718
2022-11-04 4 FORM 4 0001437749-22-026038 4626
2022-11-04 4 FORM 4 0001437749-22-026032 4627
2022-11-03 10-Q FORM 10-Q 0001437749-22-025787 001-35703 221358739 34 8202468 1 1
2022-11-03 8-K FORM 8-K 2.02,9.01 0001437749-22-025761 001-35703 221358097 34 374229 1 1
2022-10-05 4 FORM 4 0001437749-22-023679 5156
2022-10-05 4 FORM 4 0001437749-22-023677 5247
2022-10-05 4 FORM 4 0001437749-22-023673 5155
2022-09-22 8-K FORM 8-K 1.01 0001437749-22-022922 001-35703 221259512 34 160250 1 1
2022-09-07 4 FORM 4 0001437749-22-021986 5157
2022-09-07 4 FORM 4 0001437749-22-021984 5248
2022-09-07 4 FORM 4 0001437749-22-021980 5156
2022-08-10 4 FORM 4 0001437749-22-019857 13467
2022-08-10 8-K FORM 8-K 7.01 0001437749-22-019800 001-35703 221152223 34 158512 1 1
2022-08-04 4 FORM 4 0001437749-22-018993 4627
2022-08-04 4/A FORM 4/A 0001437749-22-018991 5704
2022-08-04 4 FORM 4 0001437749-22-018960 4718
2022-08-04 4 FORM 4 0001437749-22-018958 4626
2022-08-04 10-Q FORM 10-Q 0001437749-22-018920 001-35703 221137392 34 7484240 1 1
2022-08-04 8-K FORM 8-K 2.02,9.01 0001437749-22-018894 001-35703 221136859 34 378575 1 1
2022-08-02 4 FORM 4 0001437749-22-018468 5487
2022-08-02 3 FORM 3 0001437749-22-018465 9573
2022-08-02 8-K FORM 8-K 5.02 0001437749-22-018452 001-35703 221129437 34 167961 1 1
2022-08-02 424B3 FORM 424B3 0001437749-22-018442 333-266306 221129137 33 76596
2022-08-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-01 16:00:00 9999999995-22-002218 333-266306 221126735 33 1831
2022-07-28 CORRESP filename1.htm 0001437749-22-017955 8828
2022-07-27 UPLOAD filename1.pdf 0000000000-22-007906 40373
2022-07-25 S-3 pbyi20220718_s3.htm 0001437749-22-017633 333-266306 221100673 33 402136
2022-07-08 SC 13G us74587v1070_070822.txt 0000834237-22-010209 005-83367 221074937 34 12406
2022-07-07 4 FORM 4 0001437749-22-016854 12340
2022-07-07 4 FORM 4 0001437749-22-016852 5157
2022-07-07 4 FORM 4 0001437749-22-016850 12251
2022-07-07 4 FORM 4 0001437749-22-016848 12352
2022-07-07 4 FORM 4 0001437749-22-016846 12180
2022-06-21 4 FORM 4 0001437749-22-015538 4931
2022-06-21 4 FORM 4 0001437749-22-015529 6293
2022-06-21 4 FORM 4 0001437749-22-015527 4876
2022-06-21 4 FORM 4 0001437749-22-015524 4700
2022-06-17 4 FORM 4 0001437749-22-015296 4603
2022-06-17 4 FORM 4 0001437749-22-015294 4423
2022-06-17 4 FORM 4 0001437749-22-015292 4584
2022-06-17 8-K FORM 8-K 5.07 0001437749-22-015291 001-35703 221024048 34 176013 1 1
2022-06-16 4 FORM 4 0001437749-22-015215 4548
2022-06-16 4 FORM 4 0001437749-22-015212 4797
2022-06-16 4 FORM 4 0001437749-22-015210 5966
2022-06-06 4 FORM 4 0001437749-22-014437 4578
2022-06-06 4 FORM 4 0001437749-22-014434 4590
2022-06-06 4 FORM 4 0001437749-22-014432 4681
2022-06-06 4 FORM 4 0001437749-22-014429 4627
2022-05-05 4 FORM 4 0001437749-22-011162 4678
2022-05-05 10-Q FORM 10-Q 0001437749-22-011142 001-35703 22897219 34 6957563 1 1
2022-05-05 8-K FORM 8-K 2.02,9.01 0001437749-22-011132 001-35703 22896468 34 302224 1 1
2022-05-04 4 FORM 4 0001437749-22-010926 4587
2022-05-04 4 FORM 4 AUERBACH 0001437749-22-010922 4636
2022-04-29 DEFA14A FORM DEFA14A 0001437749-22-010273 001-35703 22876335 34 443099
2022-04-29 DEF 14A FORM DEF 14A 0001437749-22-010271 001-35703 22876232 34 2396467
2022-04-05 4 FORM 4 0001437749-22-008339 4555
2022-04-05 4 FORM 4 0001437749-22-008330 4609
2022-04-05 4 FORM 4 0001437749-22-008328 4517
2022-03-17 4 FORM 4 0001437749-22-006597 4981
2022-03-15 4 FORM 4 0001437749-22-006268 7061
2022-03-15 SC 13D/A SCHEDULE 13D/A 0001437749-22-006213 005-83367 22738512 34 263872
2022-03-14 4 FORM 4 0001437749-22-006207 8779
2022-03-14 4 FORM 4 0001437749-22-006190 7139
2022-03-14 4 FORM 4 0001437749-22-006188 7047
2022-03-14 4 FORM 4 0001437749-22-006180 7034
2022-03-14 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-22-006127 001-35703 22736744 34 179016 1 1
2022-03-04 4 FORM 4 0001437749-22-005306 4517
2022-03-04 4 FORM 4 0001437749-22-005303 4610
2022-03-04 4 FORM 4 0001437749-22-005301 4556
2022-03-03 10-K FORM 10-K 0001437749-22-005164 001-35703 22709728 34 9985719 1 1
2022-03-03 8-K FORM 8-K 2.02,9.01 0001437749-22-005156 001-35703 22708873 34 380374 1 1
2022-02-14 SC 13G/A PRIMARY DOCUMENT 0001654954-22-001583 005-83367 22626266 34 69527
2022-02-11 SC 13G/A e621313_sc13ga-puma.htm 0001193805-22-000263 005-83367 22621366 34 97420
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018394 005-83367 22610653 34 13098
2022-02-10 SC 13G/A PUMA_BIOTECHNOLOGY_INC.txt 0000093751-22-000059 005-83367 22609491 34 8488
2022-02-08 SC 13G PUMA BIOTECHNOLOGY, INC. 0000769993-22-000139 005-83367 22602237 34 23690
2022-02-03 4 FORM 4 0001437749-22-002423 4610
2022-02-03 4 FORM 4 0001437749-22-002412 4518
2022-02-03 4 FORM 4 0001437749-22-002408 4555
2022-02-03 SC 13G/A us74587v1070_020222.txt 0000834237-22-005482 005-83367 22585734 34 13357
2022-01-14 SC 13G PBYI_SC13G_2022.htm 0001273087-22-000007 005-83367 22531956 34 81568
2022-01-10 8-K FORM 8-K 7.01,9.01 0001437749-22-000622 001-35703 22519646 34 5880115 1 1
2022-01-05 4 FORM 4 0001437749-22-000498 5056
2022-01-05 4 FORM 4 0001437749-22-000465 5132
2022-01-05 4 FORM 4 0001437749-22-000446 5078
2022-01-05 4 FORM 4 0001437749-22-000444 5037
2021-12-14 8-K FORM 8-K 5.02 0001437749-21-028442 001-35703 211489207 34 155998 1 1
2021-12-06 4 FORM 4 0001437749-21-027964 4609
2021-12-06 4 FORM 4 - WONG 0001437749-21-027956 4516
2021-12-06 4 FORM 4 0001437749-21-027954 4517
2021-12-06 4 FORM 4 AUERBACH 0001437749-21-027952 4565
2021-11-19 SC 13G PBYI_SC13G_2021.htm 0001319244-21-000262 005-83367 211428425 34 158224
2021-11-10 SC 13G/A PUMA BIOTECHNOLOGY, INC. 0001193125-21-325976 005-83367 211396620 34 47374
2021-11-04 8-K FORM 8-K 1.01,9.01 0001437749-21-025336 001-35703 211381244 34 469726 1 1
2021-11-04 424B5 FORM 424B5 0001437749-21-025332 333-257687 211381185 33 211090
2021-11-04 10-Q FORM 10-Q 0001437749-21-025298 001-35703 211380469 34 8855384 1 1
2021-11-04 8-K FORM 8-K 2.02,9.01 0001437749-21-025291 001-35703 211380219 34 360882 1 1
2021-11-03 4 FORM 4 SUBMISSION 0001209191-21-062788 4892
2021-11-03 4 FORM 4 SUBMISSION 0001209191-21-062781 4963
2021-11-03 4 FORM 4 SUBMISSION 0001209191-21-062777 4839
2021-10-06 4 FORM 4 0001437749-21-023380 4520
2021-10-06 4 FORM 4 0001437749-21-023377 4611
2021-10-06 4 FORM 4 0001437749-21-023375 4558
2021-09-16 S-8 S-8 0001193125-21-275112 333-259585 211258021 33 121099
2021-09-07 4 FORM 4 SUBMISSION 0001209191-21-054951 4963
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054918 5361
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054896 4892
2021-08-05 10-Q 10-Q 0001564590-21-041634 001-35703 211148831 34 11702570 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001193125-21-237729 001-35703 211148435 34 277869 1 1
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049435 4893
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049429 4964
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049423 4839
2021-07-29 8-K 8-K 1.01,2.03 0001193125-21-229184 001-35703 211127435 34 153761 1 1
2021-07-16 4 FORM 4 SUBMISSION 0001209191-21-046945 5825
2021-07-16 3 FORM 3 SUBMISSION 0001209191-21-046942 3030
2021-07-14 8-K 8-K 5.02 0001193125-21-215227 001-35703 211090293 34 148725 1 1
2021-07-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-13 09:00:00 9999999995-21-002747 333-257687 211089208 33 1831
2021-07-08 CORRESP filename1.htm 0001193125-21-211030 7800
2021-07-08 UPLOAD filename1.pdf 0000000000-21-008453 40327
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045683 5360
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045599 4893
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045596 5486
2021-07-02 S-3 S-3 0001193125-21-207767 333-257687 211071506 33 140271
2021-06-25 8-K 8-K 8.01 0001193125-21-198985 001-35703 211044225 34 144051 1 1
2021-06-22 4 FORM 4 SUBMISSION 0001209191-21-042589 5759
2021-06-22 3 FORM 3 SUBMISSION 0001209191-21-042585 12527
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041803 6335
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041787 4975
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041781 4975
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041779 4920
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041731 5175
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041706 4795
2021-06-17 8-K 8-K 5.02,5.07,9.01 0001193125-21-192345 001-35703 211022862 34 203753 1 1
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040710 5157

Latest XBRL company facts

One latest value per concept from companyfacts (408 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 51.70M 2026-11-02 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
dei EntityPublicFloat Entity Public Float USD 145.20M 2025-06-30 2025 FY 10-K 2026-02-26 0001437749-26-005891
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt pure 204.07M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 125 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.43M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.06M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 58 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001437749-26-013671
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 3,280 2011-06-30 2011 Q2 10-Q 2011-08-15 0001144204-11-047512
us-gaap AccountsReceivableGross Accounts Receivable, before Allowance for Credit Loss USD 32.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 53.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 32.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 5.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 45.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 50.03M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 16.41M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013716
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 195,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 8.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 5.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.93M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -98,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.42B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 18.22M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 61,000 2011-01-01 2011-12-31 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 200,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 18.22M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 7.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AmortizationOfLeaseIncentives Amortization of Lease Incentives USD 3.00M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap Assets Assets USD 202.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AssetsCurrent Assets, Current USD 157.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 98,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 79.83M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 112.84M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2017-03-31 2017 Q1 10-Q 2017-05-10 0001564590-17-010232
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 112.85M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 79.83M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001437749-26-026311
us-gaap CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent Capital Leases, Lessor Balance Sheet, Net Investment in Direct Financing and Sales Type Leases, Current USD 17.34M 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211141
us-gaap Cash Cash USD 13.90M 2017-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 41.55M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3.15M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 100.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 72.62M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 41.55M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 9.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 67.80M 2017-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 25,467 2010-09-15 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311276
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 86.70M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005152
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Right 0.01 2011-10-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.12M 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 51.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 51.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 10.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ContractualObligation Contractual Obligation USD 67.22M 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 38.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 6.38M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap CostOfReimbursableExpense Cost of Reimbursable Expense (Deprecated 2018-01-31) USD 16.40M 2013-01-01 2013-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003090
us-gaap CostsAndExpenses Costs and Expenses USD 147.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 207,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 179,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 598,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 150,000 2010-10-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 102.00M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001437749-26-026311
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 3.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 8.67M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 3.92M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 3.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 3.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.36M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredRentAssetNetCurrent Deferred Rent Asset, Net, Current USD 195,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 5.82M 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 193,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 329.98M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 3.83M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 5.20M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 230.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.72M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 14.51M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 13.10M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 217,000 2014-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 139,000 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 1.40M 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 324.79M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts Deferred Tax Liabilities, Inventory USD 21,000 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.36M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2,000 2012-12-31 2012 FY 10-K 2013-04-01 0001193125-13-136650
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 1.70M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438277
us-gaap Depreciation Depreciation USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 7.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 233.73M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.52 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.131 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.521 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.409 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 4.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 33.80M 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap EquityIssuanceDollarAmountPerShare Equity Issuance, Amount Per Share (Deprecated 2012-01-31) USD 0 2010-12-31 2011 Q3 10-Q 2011-11-14 0001193125-11-311276
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 190 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003915
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2011-10-04 2017 FY 10-K 2018-03-09 0001564590-18-005152
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 102.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001437749-26-026311
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 18.20M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 68.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 2.44M 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 9.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.44M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 9.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 9.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 41.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 102.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 848,000 2014-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -368,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -1.18M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD -289,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.40M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001564590-17-010232
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003090
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 35.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 10.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.72 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap IncomeTaxesPaid Income Taxes Paid USD 897,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 4.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 179,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 1.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -18.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 141.15M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 179,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 7.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 12.95M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 243,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 14.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -20,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 1.70M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.53M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 26.66M 2010-09-15 2012-09-30 2012 Q3 10-Q 2012-11-14 0001193125-12-469037
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -20.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 155,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037821
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInContractReceivablesNet Increase (Decrease) in Contract Receivables, Net USD -1.76M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003090
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 7.08M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap IncreaseDecreaseInDeferredLeasingFees Increase (Decrease) in Deferred Leasing Fees USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 9,897 2010-09-15 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311276
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 5.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -82,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -1.76M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005152
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 953,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 1.18M 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-09 0001564590-17-016942
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -1,000 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-021046
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 1.18M 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 34.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InterestExpense Interest Expense USD 3.36M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-02 0001437749-24-014395
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 911,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 989,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 760,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 869,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InventoryNet Inventory, Net USD 11.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 7.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 3.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 1.22M 2014-12-31 2014 FY 10-K 2015-03-02 0001564590-15-001193
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.124 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 951,000 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 951,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 304,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 81,000 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 133,000 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 134,000 2023-03-31 2022 Q1 10-Q 2023-05-04 0001437749-23-012589
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 81,000 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 132,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001437749-25-033633
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 133,000 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 266,000 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 132,000 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 150,000 2012-06-07 2012 Q3 10-Q 2012-11-14 0001193125-12-469037
us-gaap Liabilities Liabilities USD 56.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 202.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 30.50M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap LongTermDebt Long-term Debt USD 11.34M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015633
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 11.34M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015633
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 22.67M 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 22.67M 2023-03-31 2022 Q1 10-Q 2023-05-04 0001437749-23-012589
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 22.67M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 22.67M 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 11.33M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001437749-25-033633
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2026-06-30 2026 Q2 10-Q 2026-08-06 0001437749-26-026311
us-gaap LossContingencyAccrualProvision Loss Contingency Accrual, Provision USD 2.00M 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 67.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -22.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.15M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 732,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -40,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 31.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -6.25M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 10.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -59.99M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued shares 18.67M 2011-09-01 2011-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap NontradeReceivablesNoncurrent Nontrade Receivables, Noncurrent USD 1.76M 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003915
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 150,000 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311276
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001437749-25-033633
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingExpenses Operating Expenses USD 148.14M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 9.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001437749-23-030028
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 683,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 39.76M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 4.92M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.63M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5.46M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 5.30M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 5.14M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 13.30M 2018-12-31 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 4.70M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.124 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap OtherAssetsCurrent Other Assets, Current USD 174,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 509,000 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -2,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-03 0001437749-22-025787
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -134,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherExpenses Other Expenses USD 80,000 2011-01-01 2011-12-31 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -179,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001564590-15-006819
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 1.76M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013716
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 170,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap PaymentsForMergerRelatedCosts Payments for Merger Related Costs USD 40,000 2011-09-01 2011-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD 435,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003915
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 40,000 2011-09-01 2011-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 445,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 71.11M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 82.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 44.38M 2010-09-16 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438277
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005152
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005152
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2011-06-30 2011 Q2 10-Q 2011-08-15 0001144204-11-047512
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2011-06-30 2011 Q2 10-Q 2011-08-15 0001144204-11-047512
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2011-06-30 2011 Q2 10-Q 2011-08-15 0001144204-11-047512
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 7.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.28M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 2.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 4.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PrepaidInsurance Prepaid Insurance USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PrepaidTaxes Prepaid Taxes USD 417,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 68,000 2010-10-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 161.85M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006121
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 25.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007591
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 83.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 150,000 2010-10-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 94.60M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001564590-19-031182
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.15M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026644
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 11.32M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 84,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 11,000 2019-03-31 2019 Q1 10-Q 2019-05-10 0001564590-19-018584
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 1.18M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028617
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 1.80M 2015-06-01 2015-06-30 2015 Q3 10-Q 2015-11-09 0001564590-15-010147
us-gaap RepaymentsOfDebt Repayments of Debt USD 22.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 27.20M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0001437749-22-018920
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 56.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 7.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001437749-23-005233
us-gaap RestrictedCash Restricted Cash USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 157,000 2012-06-07 2012 Q3 10-Q 2012-11-14 0001193125-12-469037
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 1.22M 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003915
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 13.17M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041793
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.27B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 156.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap Revenues Revenues USD 66.52M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015633
us-gaap RoyaltyExpense Royalty Expense USD 7.90M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211141
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 36.02M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-013008
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 52.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 9,469 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 102.46 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 471,181 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015633
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023661
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-06-15 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.87 2021-06-15 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.008 2021-06-15 2021 Q2 10-Q 2021-08-05 0001564590-21-041634
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.08M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.81M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 76.21 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 119,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 744,256 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 105,646 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 270,500 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003915
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 441,430 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 438,947 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 128,406 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 4.17 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 4.02 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.08M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.76M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 63.13 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 603,817 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 3.75 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033955
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.75 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009840
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 84.47 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.16 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 11.12 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap SharePrice Share Price USD/shares 16 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 40 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 146.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 0 2010-09-16 2010-12-31 2014 Q3 10-Q 2014-11-10 0001564590-14-005392
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 12.22M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0001437749-25-005496
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 576,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 94.93M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013716
us-gaap SubleaseIncome Sublease Income USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2026-04-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap TenantImprovements Tenant Improvements USD 1.20M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028617
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 3.40M 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003090
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 403,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 205,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 8.80M 2017-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005830
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -18.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001437749-26-005891
us-gaap VariableLeaseCost Variable Lease, Cost USD 300,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001437749-21-025298
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 25.80M 2012-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080183
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 52.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 40.64M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0001437749-22-005164
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 51.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001437749-26-035912

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →